Fat loss: supplements and training volume
Resistance training holds on to muscle, cardio creates the expenditure. Resistance volume is not reduced — in a deficit it is already tolerated worse.
Weekly volume by muscle group
The weekly set range is a working orientation from research, not a norm: inside it volume is matched to recovery.
| Muscle group | Sets per week |
|---|---|
| Chest | 8–14 |
| Back | 10–16 |
| Shoulders | 8–14 |
| Biceps | 6–10 |
| Triceps | 6–10 |
| Quadriceps | 8–14 |
| Hamstrings | 8–14 |
| Glutes | 6–12 |
| Calves | 6–10 |
| Abs and core | 4–10 |
2 times per week for each muscle group
70–85 % of 1RM
6–12
1–3 repetitions in reserve
90–180 seconds between sets
Keep the working weights. Progress in a deficit is measured not by adding weight to the bar but by maintaining strength while losing weight.
Cardio
3 sessions per week, 5 minutes per week. the bulk in zone 2 (conversational pace), plus 150 short high-intensity sessions
Add cardio gradually: first steps and low-intensity volume, high-intensity intervals last, otherwise they interfere with strength progress.
Deloads
Every 6–8 weeks, reduce volume by 30–40 % for one week.
Block: 8 weeks, progression step 0 %. Deload on week 8 with volume 35 % lower.
Limitations
- A large deficit plus a high volume of cardio sharply increases the risk of muscle loss and breakdown: calories first, cardio second.
- If strength numbers fall for two weeks in a row, reduce the deficit or the volume rather than adding training.
Supplements for this goal · 22
The level shows the strength of evidence, not importance: A means confirmed by reviews and meta-analyses, B means individual good randomised trials, C means data are scarce.
| Supplement | Level | Dose by goal |
|---|---|---|
| Conjugated linoleic acid (CLA) Meta-analysis: about 0.1 kg of fat per week at 3.2 g/day — in practice almost imperceptible | A | There are no studies for this goal — no dose is invented. |
| Caffeine A working supplement: endurance +2–4%, strength moderately | A | There are no studies for this goal — no dose is invented. |
| Whey protein Tops up daily protein; the source of protein matters less than its total amount | A | 20–40 g per serving while maintaining a calorie deficit |
| Ephedra and ephedrine A moderate weight reduction, but a serious risk to the heart | A | There are no studies for this goal — no dose is invented. |
| Betaine A small and unstable effect on strength; it changes body composition little | B | There are no studies for this goal — no dose is invented. |
| Green coffee (chlorogenic acid) Meta-analysis: about 1 kg over 8–12 weeks; the effect is small and inconsistent | B | There are no studies for this goal — no dose is invented. |
| Casein protein A slow protein; an advantage over whey is not proven | B | There are no studies for this goal — no dose is invented. |
| Leucine A separate supplement confers no advantage when protein is adequate | B | There are no studies for this goal — no dose is invented. |
| Chitosan Meta-analysis: about 1 kg over several months — practically insignificant | B | There are no studies for this goal — no dose is invented. |
| L-carnitine Does not burn fat: the average effect is about 1–1.2 kg and is clinically insignificant | B | 2–3 g per day; the maximum effect occurs at about 2 g per day |
| Garcinia cambogia The effect on weight is not confirmed; in meta-analyses there is no difference from placebo | C | There are no studies for this goal — no dose is invented. |
| Glucomannan A soluble fiber with a small effect; the evidence is weak | C | There are no studies for this goal — no dose is invented. |
| Yohimbine Dangerous: panic attacks, hypertension, prohibited in sport. Data are scarce | C | 0.2 mg/kg 30–60 minutes before fasted aerobic work is a protocol from studies, not a recommendation for use. Data are insufficient for safe use; the risk exceeds the presumed benefit |
| Raspberry ketone There is no effect in humans; the data are limited to experiments on cells and rodents | C | There are no studies for this goal — no dose is invented. |
| Creatine HCl No proven advantages over monohydrate; overpayment | C | There are no studies for this goal — no dose is invented. |
| Synephrine No benefit has been proven; there is a risk of cardiotoxicity and a rise in blood pressure | C | There are no studies for this goal — no dose is invented. |
| Theacrine The effect is NOT confirmed: a 2025 study revealed no improvement | C | There are no studies for this goal — no dose is invented. |
| Forskolin (Coleus forskohlii) Small studies of questionable quality; there is no independent confirmation of the effect | C | There are no studies for this goal — no dose is invented. |
| Sodium phosphate Results are contradictory: one study showed an effect, the second did not | C | There are no studies for this goal — no dose is invented. |
| Chromium Does not help fat loss or body composition in healthy people; data are scarce | C | 200–400 µg per day |
| Green tea extract (EGCG) The effect is small; there is a risk of rare but severe liver injury | C | 300–500 mg EGCG per day in combination with 200–300 mg of caffeine, in a course of up to 12 weeks |
| Apple cider vinegar The claimed effects on weight are not reproduced; the data of the studies raise serious doubts | C | There are no studies for this goal — no dose is invented. |
Sources by goal
- Dose-response relationship between weekly resistance training volume and increases in muscle mass: A systematic review and meta-analysis · Schoenfeld BJ, Ogborn D, Krieger JW · Journal of sports sciences, 2017 · PMID 27433992
- Comparison of concurrent, resistance, or aerobic training on body fat loss: a systematic review and meta-analysis · Lafontant K, Rukstela A, Hanson A · Journal of the International Society of Sports Nutrition, 2025 · PMID 40405489
- A systematic review and meta-analysis of interval training versus moderate-intensity continuous training on body adiposity · Keating SE, Johnson NA, Mielke GI · Obesity reviews : an official journal of the International Association for the Study of Obesity, 2017 · PMID 28513103
- Resistance training prescription for muscle strength and hypertrophy in healthy adults: a systematic review and Bayesian network meta-analysis · Currier BS, Mcleod JC, Banfield L · British journal of sports medicine, 2023 · PMID 37414459
- 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs) · Mountjoy M, Ackerman KE, Bailey DM · British journal of sports medicine, 2023 · PMID 37752011
- Effects of dietary fibre on metabolic health and obesity · Deehan EC, Mocanu V, Madsen KL · Nature reviews. Gastroenterology & hepatology, 2024 · PMID 38326443